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Abstract
Background
Diabetes among tuberculosis patients increases the risk of tuberculosis treatment failure,
death, and development of multidrug-resistant tuberculosis. Yet, there is no data is avail-
able in Bangladesh on the prevalence of diabetes among tuberculosis patients. The objec-
tive of the current study was to estimate prevalence and identify factors associated with
tuberculosis-diabetes co-morbidity among TB patients enrolled in the Directly Observed
Treatment, Short course program.
Methods
A community based cross-sectional quantitative study was conducted among 1910 tuber-
culosis patients living in six urban and eleven rural areas among whom Oral Glucose Toler-
ance Test (those who fasted) and Random Blood Sugar test (those who did not fast) were
performed. Besides glucose levels, data on socio-demographic information, family history
of diabetes and anthropometric measurements (height and weight) were also collected.
Result
Among the 1910 TB patients who participated in screening for diabetes, 245 (12.8%) were
found to have diabetes and 296 (15.5%) to have pre-diabetes. Out of those who had diabe-
tes, 34.7% were newly diagnosed through the current study and 65.3% already knew their
status. Among those who were found to have prediabetes, 27 (9.1%) had impaired Fasting
Blood Glucose (FBG), 230 (77.7%) had Impaired Glucose Tolerance (IGT), and 39 (13.2%)
had both Impaired FBG and IGT. Older age, higher BMI, higher education (secondary level
and above), being married, participation in less active work, and family history of diabetes
are associated with higher prevalence of diabetes.
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Conclusion
We observed a higher prevalence of diabetes and pre-diabetes in TB patients than reported
previously in Bangladesh among the general population which may challenge TB and dia-
betes control in Bangladesh. Diabetes diagnosis, treatment and care should be integrated
in the National TB Program.
Introduction
With the increasing pace of globalization, the disease burden in low to middle-income countries
(LMICs) is no longer limited to communicable diseases but also non-communicable diseases
(NCDs) [1]. More alarming is that the co-existence of both communicable and NCDs amplifies
the risk of developing other diseases and can adversely affect treatment outcomes [2]. One unique
example of such a combination is tuberculosis-diabetes (TB-diabetes) comorbidity. Globally, 15%
of TB patients suffer from diabetes [3]. Patients suffering from TB-diabetes, with poor glycemic
control, experience poor TB treatment outcomes such as treatment failure and death among TB
patients [4] compared to those with better glycemic control [5]. In addition, TB-diabetes patients
are more likely to developmultidrug-resistant TB (MDR-TB) [6], and have highermortality [7].
The rise of diabetes is one of the greatest threats to LMICs in the South East Asia Region
where, approximately 60% of deaths predominantly occur due to chronic NCDs like diabetes
[8]. Bangladesh is no exception to this fact. Previous studies in Bangladesh tell us about the
increase in prevalence of diabetes from 2005 to 2011 (from 8% to 15% in urban, and from 2%
to 8% in rural areas) [9,10]. Such an increase in prevalence of diabetes in a span of six years
highlights the increasing probability of higher prevalence of TB among the general population
as diabetes makes an individual prone to TB [4].
There is hardly any particular trend in the prevalences of TB reported over the last few years
in Bangladesh. The prevalence of TB in Bangladesh, according to the Global Tuberculosis
Report for 2013 [11] by theWorld Health Orgnaization (WHO) is 434 per 100,000. Following
this, the next two reports by WHO for 2014 [12] and 2015 [13] reported the prevalences to be
402 per 100,000 and 404 per 100,000 respectively. However, these numbers are not a true
representation due to lack of contribution of data as acknowledged in these reports. Neverthe-
less, such a high prevalence of TB cannot be ignored.
Prevention of TB is already a challenge in Bangladesh, with a growing number of MDR-TB
patients. On top of this, a disease like diabetes further increases the probability of TB, particularly
MDR-TB, as discussedearlier. This in turn poses a threat to TB control efforts. Although several
studies have identified the risk factors of diabetes in Bangladesh [9,10,14,15], until now no study has
looked at the prevalence of TB-diabetes comorbidity in Bangladesh and its associated factors. There-
fore it is of utmost importance that wemeasure the TB-diabetes comorbidity prevalence and deter-
mine the associated factors to propose cost-effective interventions to tackle this dual morbidity.
The current study aimed to identify prevalence and the associated factors of TB-Diabetes
comorbidity among TB patients enrolled in Direct ObservedTreatment Shortcourse (DOTS)
programme jointly run by National Tuberculosis Programme (NTP) of Bangladesh and Ban-
gladesh Rural Advancement Committee (BRAC) TB Control Programme in Bangladesh.
Methods
Study setting
This study was conducted in six purposively selected urban (Dhaka, Sylhet, Barisal, Chittagong,
Narayonganj, and Gazipur) and ten rural (Bogra,Noakhali, Dinajpur, Comilla, Narsingdi,
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Cox’s Bazaar, Kushtia, Sherpur, Manikganj, and Khagrachari) areas of Bangladesh, based on
the tuberculosis notification rate (low and high equal for urban and rural) reported by the
BRAC TB program. These areas are covered by BRAC, an NGO that works with the National
Tuberculosis Programme of Bangladesh, along with 42 other local NGOs in screening and
treating TB. More rural areas were selected due to the enrollment of fewer TB patients in the
rural DOTS centers compared to the urban areas.
Study design, population and sample size
This study was a part of a larger community based cross-sectional quantitative study on TB-
diabetes comorbidity. The larger study has two objectives. One, to determine the prevalence of
diabetes among TB patients and the associated factors. Two, to determine sputum conversion
throughout the treatment period to see whether diabetes affects sputum conversion (from Acid
Fast Bacilli (AFB) positive to AFB negative). Participants took part in the screening for diabetes
and a survey. The sampling frame consisted of patients diagnosedwith either pulmonary
(PTB) or extra pulmonary TB (EPTB) enrolled in DOTS in the selected areas. The inclusion
criteria were: aged 18 years and above and enrolled in DOTSwithin the last eight weeks, PTB
cases confirmedwith AFB positive sputum or x-ray or EPTB cases clinically confirmed follow-
ing the standard diagnostic criteria approved by Bangladesh, and initiation of treatment within
the last two months from the day of the screening [16].
A sample of 708 TB subjects was required for each category of rural and urban area, which
was calculated using the 25% prevalence of diabetes among TB patients in India, a neighboring
country which is socio-culturally similar to Bangladesh [17], 80% power, 5% level of signifi-
cance, and non-response rate of 20%. In total 1911 patients (779 for urban area and 1132 for
rural area) were recruited in the study. All patients were referred to the diagnostic facilities by
BRAC health workers, and received a transport allowance and snacks after the test. All tests
were provided free of cost.
All patients except one who voluntarily came to the diagnostic centers took part in screening
of diabetes. Although all patients were advised to fast before coming for the test, they were still
asked if they fasted. Those who fasted underwentOral Glucose Tolerance Test (OGTT)which
includedmeasurement of blood sugar during fasting and two hours after administration of
food (for those who knew their diabetes status) or 75 g glucose solution (for those who did not
know their diabetes status). Blood drawn during fasting measured fasting glucose, and the one
drawn two hours after measured glucose tolerance. For the OGTT, the following categories
adopted by World Health Organization (WHO) were used (Table 1) [18].
We adopted the following definitions in our study:
• Non-diabetes: When blood glucose for fasting and 2 hour post glucose load meets criteria for
“normal”, then it is non-diabetes.
• Pre-diabetes:We assigned pre-diabetes when either of these came true:
 A person has Impaired Fasting Glucose (IFG) and a normal glucose tolerance
Table 1. Categories for Oral Glucose Tolerance Test adopted by World Health Organization [18].
Stages Fasting 2 hr post glucose load
Normal <6.1 mmol/l <7.8 mmol/l
Impaired Fasting Glucose 6.1–<7.0 mmol/l <7.8 mmol/l
Impaired Glucose Tolerance <7.0 mmol/l 7.8–<11.1 mmol/l
Diabetes Mellitus > = 7.0 mmol/l > = 11.1 mmol/l
doi:10.1371/journal.pone.0165396.t001
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 A person has normal fasting glucose but an Impaired Glucose Tolerance (IGT)
 A person has both IFG and IGT.
• Diabetes:We assigned diabetes when either of these came true:
 Glucose level for fasting is normal but for glucose tolerance is> = 11.1mmol/l
 Glucose level for fasting is impaired but for gluocose tolerance is> = 11.1 mmol/l
 Glucose level for fasting is> = 7.0 mmol/l and for glucose tolerance is> = 11.1 mmol/l
 A person self reported having diabetes.
We also decided to determine diabetic status of those who delivered blood to measure Fast-
ing BloodGlucose (FBG) only. In this case we decided to use criteria from the “fasting” column
of Table 1. The ones who did not fast were tested for Random Blood Sugar (RBS) only, where
criteria for 2 hour post glucose load (from Table 1) were used as reference. We asked them
what they had before coming for the test and at what time they had it. We maintained the two
hour waiting period for them as OGTT.
In case of BMI, we used a cut-off point for overweight in our study that is different from the
existingWHO cut-off point for overweight. This is because, according to a WHO Expert Con-
sultation [19], Asian people with high risk of diabetes and cardiovascular diseases have BMIs
lower than the existingWHO cut-off point for overweight. It has been observed that the risk
varies from 22 kg/m2 to 31 kg/m2. Hence there is no single cut-off point. Therefore we used
BMI cut off point for overweight as> = 23 kg/m2 with reference to a review article on overview
of obesity by Ashrafuzzaman [20].
Sampling methods
We recruited the patients with the support from Program Organizers working in the BRAC TB
program. A list of all TB patients was collected from the BRAC TB Program registers in the
study sites. Out of 9458 TB patients registered for DOTS under BRAC in the selected study
sites, 7547 TB patients did not meet the inclusion criteria and thus were excluded. The number
of TB patients eligible for screening was 1911 out of which one refused to participate due to
fear of blood to be drawn. Therefore, 1910 TB patients were screened (Fig 1).
The patients were contacted the day before the diabetes screening by BRAC TB Program
organizers over telephone and/or through household visits by Shasthya Shebikas (front line
community health workers). The patients were explained the purpose and procedure of the
screeningmethod. They were infomed that they would undergo screening to determine their
diabetic status. They were instructed to fast before coming for the test and that this test would
be voluntary and free of cost. With the help of BRAC TB Program organizers, the researchers
contacted the diagnostic centers affliated with BRAC where screening took place. The person-
nel at the diagnostic centers were informed about OGTT and the number of patients they
could expect. Only the patients who came to the diagnostic centers were screened for diabetes.
Data Collection
The TB patients came early in the morning with their treatment cards to the designated diag-
nostic centers. Data collection took place in two phases: collection of blood and face-to-face
interviewusing a pre-tested questionnaire. After arrival of the patients, researchers explained
the purpose of the study and the procedure of OGTT to each participant, and took their verbal
consent and medical history of diabetes. All patients except one agreed to participate in the
TB and Diabetes: Prevalence and Associated Factors
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Fig 1. Schematic representation of number of participants screened from the study sites. TB = Tuberculosis; OGTT = Oral
Glucose Tolerance Test; RBS = Random Blood Sugar; FBG = Fasting Blood Glucose
doi:10.1371/journal.pone.0165396.g001
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screening and the survey. The one who refused to undergo screening due to fear of blood to be
drawn left the center.
In phase one, bloodwas drawn twice among those who fasted: first time immediately after
arrival, and second time two hours after administration of food (among those who reported
having diabetes), or 75g oral glucose solution (among those who did not know their diabetes
status). The first blood drawn was to measure FBG and the second blood sample was drawn to
measure Glucose Tolerance (GT). Bloodwas drawn once to measure RBS among those who
did not fast before coming for the test.
In phase two, data on family history of diabetes, demographic and socioeconomic informa-
tion, and anthropometric measurements (height and weight) were collected by the researchers.
Details of smear results of sputum tests were taken from treatment cards. The test results of the
diabetes screening were collected later in the evening on the same day or next day of the blood
glucose test, photocopied, and kept in a secure location with the researchers. The original test
results were put in a sealed envelope and handed over to BRAC TB Program organizers or
Shasthya Shebikas to be distributed to the TB patients and refer them for counselling and treat-
ment wherever appropriate.
Ethical approval
Ethical approval was obtained from the BangladeshMedical Research Council, National
Research Ethics Comitteee before starting the study. Verbal consent was taken from all patients
as many were illiterate and signing or providing fingerprint on a paper is a sensitive issue. Oral
and written information about the nature and purpose of the study were provided to all study
participants before verbal consent was taken. The participants were also informed that their
participation was voluntary and could withdraw from the study anytime. The interviewer read
the Bangla consent form to the study participant for their approval and cross checked the "yes"
option in the questionnaire. The ERC committee was aware about the cultural context and
approved this consent procedure. The TB patients who were diagnosedwith prediabetes or
newly diagnosedwith diabetes were referred to hospitals and clinics for further investigation
and management of diabetes.
Statistical Analysis
Statistical Package for Social Science (SPSS) was used for data entry and cleaning and STATA
(version 12.0) was used for all statistical analysis. The outcome variable was the presence of dia-
betes or pre-diabetes among TB patients. Descriptive univariate analysis was conducted to
determine the proportions of different categorical variables, and means and standard devia-
tions of continuous variables. Bivariate analyses such as chi-squared tests were conducted to
identify factors associated with diabetes status so that only the significant factors (p< = 0.10)
could be added in the final regression model. Since the outcome variable (diabetes status) has
three categories (no diabetes, pre-diabetes, and diabetes), multinomial logistic regression was
used to identify factors associated with TB with diabetes and pre-diabetes comorbidity.
Results
Even though all TB patients were instructed to fast before coming for the screening, not all of
them fasted. Out of 1910 TB patients, 1897 patients fasted. Among those who fasted, 19 gave
blood sample for FBG only and 1878 gave blood samples for both FBG and GT. This means
that the 13 patients who did not fast were tested for RBS. The ones who had their blood drawn
for FBG only left the diagnostic centres after first bloodwas drawn as they did not want to wait
for 2 hours.
TB and Diabetes: Prevalence and Associated Factors
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Socio-demographic profile
The mean age (including standard deviation) of the participants was 39.9 (± 15.5) years.
Among the participants, 38.7% were females, 53.1% had a family income of 5000–10,000 BDT,
40.7% never attended school, 79.5% were married, 44.4% were unemployed, and 59.2% were
from rural areas (Table 2).
Clinical profile with regards to TB
Among the participants, 1570 (82.2%) had pulmonary TB and 331 (21.8%) had EPTB. The
type of TB (PTB or EPTB) among the remaining nine (0.5%) participants was unknown. These
nine participants did not have their treatment cards with them. They were recently enrolled in
treatment regimen and had their information recorded in the program registers at the BRAC
TB Program offices but not on treatment cards at the time of data collection. The DOTS pro-
gram organizers confirmed the eligibility of patients who did not present their treatment cards.
Out of the ones who had pulmonary TB, 75.7% were confirmed through sputum and 24.3%
through x-ray (Table 2).
Prevalence of diabetes and pre-diabetes among study participants
Among the 1910 TB patients who participated in screening for DM, 245 (12.8%) were found to
have diabetes and 296 (15.5%) to have pre-diabetes (Table 2). Out of those who had diabetes,
34.7% were newly diagnosed through the current study and 65.3% already knew their diabetes
status. Among those who were found to have prediabetes, 27 (9.1%) had impaired FBG, 230
(77.7%) had IGT, and 39 (13.2%) had both Impaired FBG and IGT.
Among the 160 TB patients who knew their diabetes status, 12 (7.5%) were not engaged in
any type of intervention such as exercise, diet change, or medicine (tablet, insulin) to control
their diabetes.
Among the participants who were found to have diabetes, the majority belonged to the age
group of 45–59 years. More individuals were identifiedwith pre-diabetes (44.3%) and diabetes
(32.3%) among those who never attended school compared to the ones who had at least some
level of education. The prevalence of diabetes was higher in rural areas than urban areas
among the TB patients with diabetes (58.0% VS 42.0%). The prevalences of prediabetes and
diabetes were higher among individuals with monthly family income between 5000 to 10000
BDT compared to individuals with family income of less than 5000 BDT (Table 2).
In the current study, the majority of the participants had BMI between 18.50 and 22.99 kg/
m2. Fifty (20.4%) TB patients with diabetes were overweight (> = 23.0 kg/m2) compared to
144 (10.5%) TB patients with no diabetes.Most of the participants were also involved in mod-
erately active occupation and had no family history of diabetes. However, among the 245 indi-
viduals with diabetes, only 50 (20.4%) had a highly active occupation compared to 101 (41.2%)
and 94 (48.4%) individuals who were involved in moderately or less active occupations respec-
tively. With respect to family history of diabetes, 37 (15.1%) participants with family history of
diabetes had diabetes, compared to 21 (7.1%) and 82 (6.0%) pariticipants who were found to
have pre-diabetes or no diabetes respectively (Table 2).
Factors associated with TB-diabetes comorbidity
Age, sex, BMI, education, employment status, marital status, type of site (rural or urban), type
of occupation, and family history of diabetes were found to be associated with diabetes status
through chi-squared analysis (p =<0.10) and included in the final logistic regression model.
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Table 2. Comparison of study characteristics among TB patients screened for diabetes from July 2013 to March 2014.
Diabetic Status
Characteristics Total N = 1910 Non-diabetes Pre-diabetes Diabetes
(n = 1369) (n = 296) (n = 245)
Age (Years)
< 30 years 616 (32.2) 513 (37.5) 81 (27.4) 22 (8.9)
30–44 years 534 (28.0) 384 (28.1) 69 (23.3) 81 (33.1)
45–59 years 445 (23.3) 278 (20.3) 82 (27.7) 85 (34.7)
> = 60 years 315 (16.5) 194 (14.2) 64 (21.6) 57 (23.3)
Mean (± SD) 39.9 ± 15.5 38.0 ± 15.2 42.6 ± 16.4 47.3 ± 13.6
Sex
Male 1170 (61.3) 816 (59.6) 193 (65.2) 161 (65.7)
Female 740 (38.7) 553 (40.4) 103 (34.8) 84 (34.3)
Educational Status
Never attended school 778 (40.7) 568 (41.5) 131 (44.3) 79 (32.3)
Primary education 478 (25.1) 349 (25.5) 65 (21.9) 64 (26.1)
Secondary education 379 (19.8) 268 (19.6) 60 (20.3) 51 (20.8)
SSC and above 275 (14.4) 184 (13.4) 40 (13.5) 51 (20.8)
Marital Status
Never Married 279 (14.6) 223 (16.3) 48 (16.2) 8 (3.2)
Married 1519 (79.5) 1069 (78.1) 234 (79.1) 216 (88.2)
Widow/Widower/Divorced/Separated 112 (5.9) 77 (5.6) 14 (4.7) 21 (8.6)
Employment status
Unemployed 848 (44.4) 612 (44.7) 137 (46.3) 99 (40.4)
Employed 940 (49.2) 691 (50.5) 132 (44.6) 117 (47.8)
Retired 122 (6.4) 66 (4.8) 27 (9.1) 29 (11.8)
Monthly Family Income (BDT)
<5000 329 (17.2) 240 (17.5) 55 (18.6) 34 (13.9)
5000 to 10,000 1088 (57.0) 796 (58.2) 162 (54.7) 130 (53.1)
>10,000 493 (25.8) 333 (24.3) 79 (26.7) 81 (33.0)
Site type
Rural 1131 (59.2) 816 (59.6) 173 (58.4) 142 (58.0)
Urban 779 (40.8) 553 (40.4) 123 (41.6) 103 (42.0)
TB classification
Pulmonary TB 1570 (82.2) 1122 (82.0) 241 (81.4) 207 (84.5)
Extra-pulmonary TB 331 (17.3) 241 (17.6) 53 (17.9) 37 (15.1)
Unknown 9 (0.5) 6 (0.4) 2 (0.7) 1 (0.4)
Type of TB cases
New cases 1876 (98.2) 1348 (98.5) 292 (98.7) 236 (96.3)
Previously treated 34 (1.8) 21 (1.5) 4 (1.3) 9 (3.7)
Type of occupation
Highly active 551 (28.9) 417 (30.5) 84 (28.4) 50 (20.4)
Moderately active 868 (45.4) 646 (47.2) 121 (40.9) 101 (41.2)
Less active 491 (25.7) 306 (22.3) 91 (30.7) 94 (38.4)
BMI
Normal (18.50–22.99) 1004 (52.6) 744 (54.4) 166 (56.1) 94 (38.4)
Underweight (<18.50) 672 (35.2) 481 (35.1 90 (30.4) 101 (41.2)
Overweight/obese (> = 23.00) 234 (12.2) 144 (10.5) 40 (13.5) 50 (20.4)
Family History of Diabetes
(Continued )
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All these variables except sex were found to be significantly associated with diabetes status
(Table 3).
In multinomial logistic regression, several factors were associated with being diagnosedwith
diabetes and pre-diabetes. Both diabetes and pre-diabetes were significantly associated with
older age. It was revealed that TB patients aged more than 30 years are at significantly higher
risk of having diabetes than those aged less than 30 years. Higher chances of diabetes have been
found to be associated with an education level of SSC and above with an odds ratio of 2.63
(95% C.I 1.63–4.27). The regression model further determined that married TB patients are
2.66 (95% C.I 1.18–5.99) times more likely to have diabetes than those who are never married
(Table 3).
Discussion
To the best of our knowledge, this is the first study in Bangladesh that reports the prevalence of
diabetes and pre-diabetes among TB patients. The current study aimed to determine the preva-
lence of diabetes and pre-diabetes among TB patients and the factors associated with TB-diabe-
tes comorbidity. The prevalences of diabetes and pre-diabetes were found to be 12.8% and
15.5% respectively. The factors significantly associated with TB-diabetes comorbity were age
(more than 30 years), education level of SSC and above, beingmarried, less active occupation,
higher BMI, and presence of family history of diabetes.
The prevalence of diabetes among TB patients reported in this study is lower than that
reported in India in 2012 [17] (prevalence of diabetes being 25.3%), which shares socio-eco-
nomic similarities with Bangladesh. However, we observed a higher prevalence of diabetes in
the TB population than in the general population of Bangladesh as reported from a nationwide
survey [10] (prevalence: 9.7%) and a systemic review [21] (pooled prevalence: 6.7%). The
higher prevalence of diabetes found in our study could be due to our study design where we
actively screened people from the community. The high prevalence of diabetes can also be
attributed to TB status as diabetes can weaken the immune system and make patients prone to
TB [22].
Moreover, the current study reported a higher number of individuals with diabetes in the
rural areas compared to Akter et al (10). One reason could be the poor screening of diabetes in
rural areas.
We also observed a lower prevalence of pre-diabetes (15.5%) in our study compared to the
one by Akter et al (15.5% VS 23.0%) [10] [. This suggests that there may be an increased risk of
diabetes in Bangladesh in the future. Overall, the alarming increases of diabetes and pre-diabe-
tes indicate a threat to TB control and demands a need of increasing awareness regarding life-
style changes.
The study participants with diabetes and pre-diabetes were significantly older than partici-
pants with no diabetes or pre-diabetes. The association of increasing age with diabetes evident
Table 2. (Continued)
Diabetic Status
Characteristics Total N = 1910 Non-diabetes Pre-diabetes Diabetes
(n = 1369) (n = 296) (n = 245)
Absent 1770 (92.7) 1287 (94.0) 275 (92.9) 208 (84.9)
Present 140 (7.3) 82 (6.0) 21 (7.1) 37 (15.1)
BMI = Body Mass Index; TB = Tuberculosis; SSC = Secondary School Certificate
doi:10.1371/journal.pone.0165396.t002
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Table 3. Multinomial logistic regression analysis for factors associated with pre-diabetes and diabetes among study subjects.
Number of TB patients screened for diabetes Pre-diabetes Diabetes
N = 1910 n = 296 n = 245
n (%) OR (95% CI) OR (95% CI)
Age
< 30 years 616 (32.2) - -
30–44 years 534 (28.0) 1.39 (0.93–2.08) 4.73 (2.77–8.09)***
45–59 years 445 (23.3) 2.56 (1.65–3.98)*** 8.72 (4.89–15.52)***
> = 60 years 315 (16.5) 2.54 (1.54–4.20)*** 8.67 (4.55–16.52)***
Sex
Male 1170 (61.3) - -
Female 740 (38.7) 0.97 (0.66–1.43) 0.86 (0.54–1.39)
Educational Status
Never attended school 778 (40.7) - -
Primary education 478 (25.1) 0.95 (0.67–1.34) 1.71 (1.16–2.52)**
Secondary education 379 (19.8) 1.19 (0.81–1.75) 2.23 (1.44–3.44)***
SSC and above 275 (14.4) 1.01 (0.64–1.61) 2.63 (1.63–4.27)***
Marital Status
Never Married 279 (14.6) - -
Married 1519 (79.5) 0.68 (0.44–1.05) 2.66 (1.18–5.99)*
Widow/Widower/Divorced/ 112 (5.9) 0.41 (0.19–0.91)* 3.39 (1.21–9.46)*
Separated
Employment status
Unemployed 848 (44.4) - -
Employed 940 (49.2) 0.68 (0.49–0.94)* 0.78 (0.52–1.17)
Retired 122 (6.4) 1.09 (0.63–1.89) 1.23 (0.68–2.20)
Monthly Family Income (BDT)
<5000 329 (17.2) - -
5000 to 10,000 1088 (57.0) 0.91 (0.64–1.30) 1.15 (0.75–1.78)
>10,000 493 (25.8) 1.06 (0.70–1.59) 1.46 (0.90–2.36)
Site type
Rural 1131 (59.2) - -
Urban 779 (40.8) 1.19 (0.90–1.57) 1.18 (0.86–1.62)
Type of occupation
Highly active 551 (28.9) - -
Moderately active 868 (45.4) 0.94 (0.63–1.40) 1.29 (0.78–2.12)
Less active 491 (25.7) 1.47 (1.03–2.09)* 1.83 (1.20–2.78)**
BMI
Normal (1850–2299) 1004 (52.6) - -
Underweight (<1850) 672 (35.2) 0.85 (0.63–1.13) 1.45 (1.05–2.02)*
Overweight/obese (> = 2300) 234 (12.2) 1.30 (0.86–1.95) 2.09 (1.36–3.21)**
Family History of Diabetes
None of the parents 1770 (92.7) - -
At least one parent 140 (7.3) 1.33 (0.79–2.23) 3.06 (1.89–4.96)***
*P values between 0.05–0.01
**P values between 0.01–0.001
***P values less than 0.001
BMI = Body Mass Index; TB = Tuberculosis; SSC = Secondary School Certificate
doi:10.1371/journal.pone.0165396.t003
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from the study is consistent with past studies conducted in India [17,23,24] and China [25].
Increasing age has been established to be associated with both TB and diabetes through previ-
ous studies [26,27].
In the current study, TB patients with lower BMI have been observed to have a lower risk of
diabetes than those with higher BMI. From the literature, we do know that lower BMI and dia-
betes make an individual more prone to TB [28]. This means with increasing BMI, although
the risk of diabetes increases, the risk of TB decreases [29]. But the increasing prevalence of dia-
betes, as evident through our study, suggests more occurrence of TB, hence raising the co-mor-
bidity of TB and diabetes [30]. Therefore, the importance of undertaking interventions to
reduce TB-diabetes comorbidity cannot be neglected.
We also observed that family history of diabetes has a strong significant association with
occurrence of diabetes. This means those who have family history of diabetes are at more risk
of having diabetes than those who do not. Our study reports a considerably higher number of
individuals with TB-diabetes comorbidity with family history of diabetes which is not surpris-
ing. This is consistent with studies conducted in Bangladesh [31] and other parts of the world
as well [16,20,21]
Among the study participants diagnosedwith diabetes, around 65% of themwere previously
diagnosed, indicating 35% were newly diagnosed through our study. It has already been estab-
lished that diabetes acts as a risk factor for TB as it can worsen the immune response needed to
prevent occurrence of TB. This could be a reason for the higher prevalence of diabetes in the
current study. The other reason could be that we screened TB patients who were already on
treatment. The literature suggests that TB induces hyperglycemia and mimics diabetes in non-
diabetic patients [32]. In addition, post initiation of anti-tubercular treatment, TB drugs such
as rifampicin and isoniazidmay also induce hyperglycemia by enhancing the metabolism of
hypoglycemic agents in anti-diabetes drugs, and impairing insulin secretion in non-diabetics
[32,33]. It may even worsen glucose control in diabetes patients, which may require changes in
the dose of insulin [34]. Thus, over-diagnosis of diabetes in TB patients might occur if screen-
ing for glucose is not conducted prior to initiation or after finishing TB treatment. All the
respondents in our study were screened for diabetes after initiation of TB treatment that could
lead to over-diagnosis. However, this provides an opportunity for the patients to receive an
intervention, earlier on, for better control and treatment outcomes, if/when needed.More
research should be conducted to find the ideal time for diabetes screening. Glucose levels
should be measured repeatedly before, during and after completion of TB treatment to deter-
mine true diabetic status.
The strengths of the study comprise the large number of TB patients screened for diabetes
reducing selection bias in the process, determining prevalence of both diabetes and pre-diabe-
tes among TB patients in Bangladesh, using OGTTmethod to screen diabetes, and covering
urban and rural areas. However, limitations should also be mentioned.We could not perform
OGTTamong all the patients. We performedRBS among those who did not fast and only FBG
among those who did not complete OGTT. Tests such as RBS and FBG have lower sensitivity
than OGTT [23,35]. There is a possibility of underestimating the prevalence of diabetes and
pre-diabetes among those who took part to measure RBS and FBG only. Even though OGTT
was a strength for the current study, it also acted as a limitation. For an OGTT, it is required to
fast for 8 hours before giving blood for FBS, and further requires the individual to wait for 2
hours before the blood can be drawn again to measure GT. Such strict requirements become a
burden for a sick person such as a TB patient. In addition, the timing of screening posed a
problem as well. Most of the participants in our study needed to go to work early morning.
While some could not complete the OGTTprocedure, some had to take leave and/or report
late to work, causing furthermental and physical stress. In addition, our study findings can
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only be generalized for patients diagnosedwith TB but not to other vulnberable populations.
Last but not the least, recruiting TB patients on treatment raises a possibility of overestimating
the prevalence of diabetes, as previously mentioned.
As diabetes is a risk factor for TB, an ideally effective TB control program could expand and
incorporate diabetes care among individuals with active TB; however funding is a challenge.
Therefore, co-management of both the diseases could be limited to active TB patients only
[36]. TheWorld Health Organization along with the International Union Against Tuberculosis
and Lung Diseases developed a collaborative framework for care and control of TB and diabe-
tes, which highly recommends bidirectional screening for both [37].
The importance of screening for diabetes in TB patients cannot be ignored. In low-resource
countries, there is a lack of screening of diabetes and inadequate diabetes control. But diabetes
is rising gradually due to socioeconomicand lifestyle changes [38]. The relative contribution of
diabetes to TB epidemic will be 125% in 2030, an increase of 255% compared to 2010. In
countries with a high TB burden, in particular, the risk for TB is three times more in diabetic
patients [38]. In LMICs, TB patients are usually not screened for diabetes as a part of the man-
agement of TB control, partly due to cost and complexity [39]. For this reason, different screen-
ing approaches have been proposed, including diabetes risk assessment surveys, and use of
suitable, rapid, inexpensive screening tools appropriate for TB patients in LMICs. Countries
like Bangladesh depend on OGTTas the gold standard to detect diabetes, but this method
requires a clinical setting with a long waiting time and multiple blood samples. Other screening
methods such as point-of-care glycated haemoglobin and glycated albumin assays, and sudo-
motor function-based screening devices are currently being explored [39].
The high prevalence of pre-diabetes in the current study underscores the importance for
preventive measures for diabetes. Factors revealed in this study may increase the risk of diabe-
tes along with other factors like use of tobacco, unhealthy diets, and lack of physical activities
[10,14]. Tuomilehto et al. in 2001 followed a cohort of glucose-impaired subjects for three
years and observeddecreased incidence of diabetes due to changes in lifestyle [40].
Nevertheless, awareness regarding TB- diabetes comorbidity should be raised among the
DOTS implementers. Tuberculosis control programs in Bangladesh should incorporate routine
screening of diabetes in TB patients and refer them to diabetes care facilities. Such an undertak-
ing would require training for capacity building, as well as improvement in infrastructure. This
means a greater collaborationmust take place between the National Tuberculosis Program
Bangladesh and the Diabetic Association of Bangladesh (DAB) to ensure guidelines are revised
to respond to the dual burden.
In conclusion, the current study reported a high prevalence of diabetes and pre-diabetes
among TB patients which may challenge TB and diabetes control in Bangladesh. Therefore
future research should focus on reducing TB and diabetes comorbidity.
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